Enter your login e-mail to the account
Search
- Obesity and arterial hypertension
Doc. MUDr. Ľudovít Gašpar, CSc.
(5/2017, Topic of the year ) - Potreba fixných kombinácií v liečbe artériovej hypertenzie
MUDr. Peter Jonáš
(3/2004, Topic ) - Patofyziológia a farmakoterapia hypertenzného srdca
prof. MUDr. Fedor Šimko, CSc., FESC
(S1/2011, Supplement ) - Calcium – bone and cardiovascular effects
MUDr. Mária Rašková, Ph.D.
(3/2015, Electronic attachment ) - Fixed-dose combinations of calcium channel blockers and angiotensin-converting enzyme inhibitors in hypertension
MUDr. Slavomír Šuch
(3/2010, Drugs & drug classes ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - PATHOPHYSIOLOGY OF HEART FAILURE
prof. MUDr. Fedor Šimko, CSc.
(9/2006, Main topic ) - TREATMENT OF PATIENT WITH CONGESTIVE HEART FAILURE
prof. MUDr. Ján Murín, CSc.
(9/2006, Main topic ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles )
- Hypertrophic cardiomyopathy in children
MUDr. Michal Chalupka, doc. MUDr. Peter Olejník, PhD., MUDr. Jaroslav Tomko, MUDr. Marko Bjeloševič, PhD., MUDr. Viera Illíková, PhD.
(5/2021, Review articles ) - Hypertension in children: an exception or a rising trend?
Prof. MUDr. Tomáš Seeman, CSc., MBA
(2/2023, Review articles )
- STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - COMBINATION THERAPY FOR HYPERTENSION
Doc. MUDr. Milan Grundmann, CSc., MUDr. Ivana Kacířová
(2/2007, clearly )
- Rilmenidine use in clinical practice
MUDr. Martin Čaprnda, PhD.
(1/2014, Clinical pharmacy )
- Primary aldosteronism – endocrine disease with cardiovascular manifestations
MUDr. Tomáš Zelinka, prof. MUDr. Jiří Widimský, CSc.
(3/2011, Original articles & Case reports )